+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-tumor activity of N-thiolated beta-lactam antibiotics



Anti-tumor activity of N-thiolated beta-lactam antibiotics



Cancer Letters 268(1): 63-69



An ongoing strategy for cancer treatment is selective induction of apoptosis in cancer over normal cells. N-thiolated beta-lactams were found to induce DNA damage, growth arrest and apoptosis in cultured human cancer cells. However, whether these compounds have a similar effect in vivo has not been studied. We report here that treatment with the beta-lactam L-1 caused a significant inhibition of tumor growth in a breast cancer xenograft mouse model, associated with induction of DNA damage and apoptosis in vivo. These results suggest that the synthetic antibiotic N-thiolated beta-lactams hold great potential to be developed as novel anti-cancer drugs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051571166

Download citation: RISBibTeXText

PMID: 18468785

DOI: 10.1016/j.canlet.2008.03.047


Related references

Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring. International Journal of Molecular Medicine 21(6): 689-695, 2008

Novel N-thiolated beta-lactam antibiotics selectively induce apoptosis in human tumor and transformed, but not normal or nontransformed, cells. Biochemical Pharmacology 67(2): 365-374, 2004

N-Thiolated beta-lactam antibacterials: effects of the N-organothio substituent on anti-MRSA activity. Bioorganic & Medicinal Chemistry 14(11): 3775-3784, 2006

N-thiolated beta-lactam antibiotics. Official Gazette of the United States Patent & Trademark Office Patents 1264(1), 2002

Chemistry and biology of N-thiolated beta-lactam antibiotics. Abstracts of Papers American Chemical Society 224(1-2): MEDI 46, 2002

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Diagnostic Microbiology and Infectious Disease 54(2): 135-139, 2006

In vitro, anti-microbial activity of a novel beta-lactam antibiotics, YH-487. Agricultural Chemistry & Biotechnology 40(1): 23-29, 1997

Ceftazidime in vitro anti bacterial activity and susceptibility to beta lactamases compared with that of cefotaxime moxalactam and other beta lactam antibiotics. Journal Of Antimicrobial Chemotherapypl. B: 23-32, 1981

Effects of inducible beta lactamase and anti microbial resistance on activity of newer beta lactam antibiotics against pseudomonas aeruginosa. Journal of Antibiotics 34(10): 1334-1340, 1981

The anti microbial activity of mecillinam in combination with beta lactam antibiotics. Abstracts of the Annual Meeting of the American Society for Microbiology 80: ABSTRACT 1999, 1980

Effect of sulbactam on anti-pseudomonal activity of beta-lactam antibiotics in cells producing various levels of the MexAB-OprM efflux pump and beta-lactamase. Microbiology and Immunology 44(12): 997, 2000

Studies on beta lactam antibiotics 7. effect on anti bacterial activity of the oxime o substituents with various functional groups in the 7 beta z 2 2 amino 4 thiazolyl 2 oxyiminoacetamido cephalosporins. Journal of Antibiotics 36(7): 846-854, 1983

In vitro anti microbial activity of piperacillin and 7 other beta lactam antibiotics against neisseria gonorrhoeae and haemophilus influenzae including beta lactamase producing strains. Journal of Antimicrobial Chemotherapy 5(2): 137-142, 1979

Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 17(2): 129-131, 1980

Theoretical studies on beta-lactam antibiotics. IV. Conformational analysis of novel beta-lactam antibiotics and the binding specificities of crosslinking enzyme(s) and beta-lactamases. Biopolymers 20(5): 865-877, 1981